Simos Kedikoglou, MD

Dr. Simos Kedikoglou has been actively involved in medical technology development, helping bring life-changing innovations to patients while delivering value to shareholders. Prior to joining Anumana, Simos served as CEO of Impulse Dynamics, a company that commercialized the first active implantable heart failure breakthrough device, a groundbreaking innovation approved in the U.S., Europe, and China. He also served as an Executive Board Member at MedAlliance, a company that developed a breakthrough sirolimus-eluting balloon. In these roles,

Simos has also served as the Corporate Vice President of Business Development at Boston Scientific, where he oversaw acquisitions, licensing, and distribution deals across the U.S., Europe, and Asia.  Earlier in his career, he was an Associate Partner at McKinsey & Company in the U.S., advising healthcare clients on mergers and acquisitions.

Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction from Harvard Business School, a Master’s in Public Health from Harvard University, and is a CFA charter holder.